T43.212A Poisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm, initial encounter

Name of the Condition

• Poisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm, initial encounter

Summary

This condition involves intentional self-harm resulting from an overdose of selective serotonin and norepinephrine reuptake inhibitors (SNRIs), a class of antidepressant medications. It is classified as an initial encounter, indicating the patient is receiving care for the poisoning event for the first time. Diagnosis is based on clinical presentation, medication history, and confirmation of intentional exposure.

Causes

Intentional self-harm occurs when an individual purposefully ingests an excessive amount of SNRIs, typically as a deliberate act. This may involve taking more than the prescribed dose or consuming medication not intended for them, often driven by underlying mental health concerns.

Risk Factors

• History of depression, anxiety, or other mental health disorders
• Prior suicide attempts or suicidal ideation
• Access to SNRIs without supervision
• Concurrent substance use or alcohol consumption
• Social isolation or lack of support systems

Symptoms

• Nausea, vomiting, or abdominal pain
• Dizziness, drowsiness, or confusion
• Rapid heart rate or changes in blood pressure
• Tremors, seizures, or muscle rigidity
• Excessive sweating, fever, or respiratory distress

Diagnosis

Diagnosis is based on a thorough patient history, including medication use and circumstances of exposure, along with clinical assessment of symptoms. Laboratory tests may be used to confirm the presence of SNRIs or rule out other causes. Documentation of intent is critical for accurate coding.

Treatment Options

Treatment focuses on stabilizing the patient, which may include activated charcoal, gastric lavage, or supportive care. Antidotes are not available for SNRIs, so management is primarily symptomatic. Psychiatric evaluation and intervention are essential to address underlying mental health concerns.

Prognosis and Follow-Up

Prognosis depends on the severity of the overdose and timely intervention. Most patients recover with appropriate treatment, but severe cases may result in long-term complications. Follow-up care should include ongoing psychiatric support and monitoring for recurrence.

Complications

• Seizures or neurological damage
• Cardiac arrhythmias or heart failure
• Respiratory failure requiring mechanical ventilation
• Metabolic imbalances (e.g., hyponatremia)
• Persistent mental health issues or suicidal ideation

Lifestyle & Prevention

• Secure storage of medications to prevent access
• Regular mental health check-ins and therapy
• Education on proper medication use and dosage
• Avoidance of alcohol or other substances that may interact with SNRIs
• Building a support network to address emotional distress

When to Seek Professional Help

Seek immediate medical attention if you or someone else has ingested an excessive amount of SNRIs, especially if intentional self-harm is suspected. Signs of overdose, such as confusion, seizures, or difficulty breathing, require urgent care.

Tips for Medical Coders

This code (T43.212A) is specific to intentional self-harm with SNRIs during the initial encounter. Documentation must clearly indicate intent (e.g., patient statement, witness report) and the nature of the exposure. Ensure the encounter is classified as "initial" to align with the code’s specificity.